MELD score and AST-to-platelet ratio index predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study

Abstract

Aim: Liver transplantation (LT) is the most effective treatment for long-term survival from hepatocellular carcinoma (HCC); however, insufficient donors limit therapy. The authors sought to identify characteristics that predicted long-term survival after non-transplant therapies in patients with small HCC.

Methods: In a database of 1,050 HCC patients, the authors identified those with single HCC ≤ 3.0 cm, who underwent hepatic resection (HR, n = 16), radiofrequency ablation (RFA, n = 55), or LT (n = 23) with 5-year follow-up. Overall survival (OS) and odds-ratios (OR) for survival after HR/RFA were calculated for MELD score, platelet count, creatinine, albumin, AST/platelet ratio index (APRI), international normalized ratio, and bilirubin.

Results: LT patients had 3- and 5-year OS of 82.6% and 73.9% compared to HR/RFA patients with 3- and 5-year OS of 40.8% and 33.8%. The strongest predictors of survival after HR/RFA were MELD < 10 [OR 4.43, 95% confidence interval (CI) 1.85-10.58] and APRI ≤ 0.5 (OR 4.25, 95% CI 1.63-11.08). HR/RFA patients with both MELD < 10 and APRI ≤ 0.5 had 3- and 5-year OS of 77.3% and 72.7%.

Conclusion: Patients with MELD < 10 and APRI ≤ 0.5 who undergo HR/RFA have survival approaching LT. Perhaps patients who meet these criteria can safely undergo non-transplant therapy and donor livers can be allocated to patients with a greater need.

Keywords

Hepatocellular carcinoma / ablation / liver resection / transplant

References

[1] Mittal S.Epidemiology of HCC: consider the population..J Clin Gastroenterol2013;47:S2-6

[2] Ferlay J,Dikshit R,Mathers C,Parkin DM,Bray F.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012..Int J Cancer2015;136:E359-86

[3] Belghiti J.Transplantation for liver tumors..Semin Oncol2005;32:29-32

[4] Yao FY,Nikolai B,Kerlan R,Ascher NL.Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list..Liver Transpl2002;8:873-83

[5] Adam R,Vibert E,Pelletier G,Samuel D,Castaing D.Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?.Ann Surg2012;256:883-91

[6] Ogihara M,Machi J.Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes..HPB (Oxford).2005;7:214-21 PMCID:PMC2023955

[7] Ueno S,Kubo F,Tateno T,Hasegawa S.Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria..J Hepatobiliary Pancreat Surg2009;16:359-66

[8] Lu XY,Lau WY,Xian ZH,Zhu Z,Wu MC.Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior..J Cancer Res Clin Oncol2011;137:567-75

[9] Wai CT,Fontana RJ,Marrero JA,Lok AS.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C..Hepatology2003;38:518-26

[10] Farinati F,Baldan A,Di Nolfo MA,Benvegnu L,Zoli M,Giannini EG,Trevisani F.Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study..BMC Cancer2009;9:33 PMCID:PMC2640412

[11] Hsueh KC,Kor CT,Chang TM,Hsieh CB.The role of liver transplantation or resection for patients with early hepatocellular carcinoma..Tumour Biol2016;37:4193-201

[12] Zhou Z,Li B,Wang W,Cheng K.Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule < 2 cm): a single-center study..Eur J Gastroenterol Hepatol2014;26:339-44

[13] Chapman WC,Hemming A,Majella Doyle MB,Zaydfudim V,Cavaness K,Zendajas I,Nagorney D.Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?.J Am Coll Surg2015;220:628-37

[14] Seshadri RM,Niemeyer DJ,McKillop IH,Martinie JB,Iannitti DA.Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection..HPB (Oxford).2014;16:1102-9 PMCID:PMC4253334

[15] Bellavance EC,Mentha G,Capussotti L,Majno P,Rubbia-Brandt L,Aldrighetti L,Russolillo N,Barroso E.Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?.J Gastrointest Surg2008;12:1699-708

[16] Zheng Z,Milgrom DP,Schroder PM,Yang C,He X.Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies..Transplantation2014;27:227-34

[17] Liu PH,Hsia CY,Huang YH,Lin HC.Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma ≤ 2 cm in a propensity score model..Ann Surg2016;263:538-45

[18] Mehta N,Dodge JL,Roberts JP.Intention to treat outcome of T1 hepatocellular carcinoma with the "Wait and Not Ablate" approach until meeting the T2 criteria for liver transplant listing..Liver Transplant2016;22:178-87 PMCID:PMC4803445

[19] Wong RJ,Valenzuela A,Bonham C,Melcher ML,Concepcion W,Garcia G,Nguyen MH.Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients..Dig Dis Sci2014;59:183-91

[20] Portolani N,Ghidoni S,Benetti A,Giulini SM.Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications..Ann Surg2006;243:229-35 PMCID:PMC1448919